Gary R. McLean

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

Yasmin Abo‐zeid, Nasser S. M. Ismail, Gary R. McLean et al. · European Journal of Pharmaceutical Sciences · 2020 · 230 citations · Full text

Nanoparticles, Nanomedicine, Covid-19 Infection +9

Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies

Ilona Baraniak, Barbara Kropff, Lyn Ambrose et al. · Proceedings of the National Academy of Sciences · 2018 · 115 citations · Full text

Isotype Can Affect the Fine Specificity of an Antibody for a Polysaccharide Antigen

Gary R. McLean, Marcela Torres, Natalia Elguezábal et al. · The Journal of Immunology · 2002 · 97 citations

Cross-Serotype Immunity Induced by Immunization with a Conserved Rhinovirus Capsid Protein

Nicholas Glanville, Gary R. McLean, Bruno Guy et al. · PLoS Pathogens · 2013 · 88 citations · Full text

Viral Pathogenesis, Immunology, Immunodominance +18

Germline V‐genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus

Christy A. Thomson, S. Bryson, Gary R. McLean et al. · The EMBO Journal · 2008 · 71 citations · Full text